Talk:Corticosteroid 11-beta-dehydrogenase isozyme 2

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Requested move 19 June 2015

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review. No further edits should be made to this section.

The result of the move request was: not moved. Jenks24 (talk) 11:43, 14 July 2015 (UTC)[reply]

Corticosteroid 11-beta-dehydrogenase isozyme 2 → 11β-hydroxysteroid dehydrogenase type 2 – "11-β HSD2" is a more common name. This is shown in journals: eg last quotation in this page; last 2 quotation of "11β-HSD1", as well as in wikipedia in language of Franch/Italian. This can align with the naming of 11beta HSD-1. Relisted. Jenks24 (talk) 14:24, 7 July 2015 (UTC) --Relisted. George Ho (talk) 05:34, 26 June 2015 (UTC) Liwk (talk) 08:15, 19 June 2015 (UTC)[reply]

Oppose. The proposed is more jargonesque. The sources alluded include jargon. Prefer corticosteroid as more specific and a much better article than hydroxysteroid. --SmokeyJoe (talk) 00:34, 7 July 2015 (UTC)[reply]
Oppose WP:AT special characters. "beta" is also found in literature, so there is no advantage to using an untypable character. -- 67.70.32.20 (talk) 04:44, 9 July 2015 (UTC)[reply]

The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page or in a move review. No further edits should be made to this section.